Compare Agilent Technologies Inc (A) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Verisign, Inc. — how do they compare? Agilent Technologies Inc trades at $148.16 (market cap $42.22B), while Verisign, Inc. trades at $283.47 (market cap $26.00B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Verisign, Inc. pays the higher dividend (1.13%). Which is the better fit depends on your goals.
| A | VRSN | |
|---|---|---|
Market Cap | $42.22B | $26.00B |
Sector | Health | Technology |
52-Week High | $157.20 | $310.00 |
52-Week Low | $110.24 | $211.49 |
Enterprise Value | $43.77B | $27.31B |
Dividend Yield | 0.68% | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.
VeriSign (VRSN) trades at $293.34, down 0.41% with a bullish technical outlook supported by moving averages. The company reported strong Q2 2026 results with record domain registrations and 6% revenue growth, maintaining robust profit margins near 50%. Recent delegation of .web domain and AI-driven registration growth provide positive catalysts.
The stock offers 9% upside to consensus price target of $320 with 60% analyst buy ratings. Key risks include contract renewals and premium valuation at 31x P/E. Strong cash flow generation and dividend payments support shareholder returns amid stable internet infrastructure demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
